IRRAS Wins Regulatory Approval of IRRAflow(R) in Israel and Costa Rica
STOCKHOLM, June 25, 2019 -- (Healthcare Sales & Marketing Network) -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, announced today... Devices, Neurosurgery, Monitoring, Regulatory IRRAS, IRRAflow catheter, ICP monitoring
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Costa Rica Health | Israel Health | Marketing | Middle East Health | Neurology | Neurosurgery | Pharmaceuticals